U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Sparfloxacin

Last Revision: February 15, 2021.

Estimated reading time: 1 minute

CASRN: 110871-86-8

image 135018692 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the use of sparfloxacin during breastfeeding. Fluoroquinolones have traditionally not been used in infants because of concern about adverse effects on the infants' developing joints. However, recent studies indicate little risk.[1,2] The calcium in milk might prevent absorption of the small amounts of fluoroquinolones in milk,[3] but insufficient data exist to prove or disprove this assertion. Use of sparfloxacin is acceptable in nursing mothers with monitoring of the infant for possible effects on the gastrointestinal flora, such as diarrhea or candidiasis (thrush, diaper rash). However, it is preferable to use an alternate drug for which safety information is available.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Ciprofloxacin, Levofloxacin

References

1.
Gürpinar AN, Balkan E, Kiliç N, et al. The effects of a fluoroquinolone on the growth and development of infants. J Int Med Res. 1997;25:302–6. [PubMed: 9364293]
2.
van den Oever HL, Versteegh FG, Thewessen EA, et al. Ciprofloxacin in preterm neonates: Case report and review of the literature. Eur J Pediatr. 1998;157:843–5. [PubMed: 9809826]
3.
Fleiss PM. The effect of maternal medications on breast-feeding infants. J Hum Lact 1992;8:7. Letter. PMID: 1558663. [PubMed: 1558663]

Substance Identification

Substance Name

Sparfloxacin

CAS Registry Number

110871-86-8

Drug Class

Breast Feeding

Lactation

Anti-Infective Agents

Antibacterial Agents

Quinolones

Fluoroquinolones

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK501100PMID: 30000159

Views

Related information

Similar articles in PubMed

  • Review Lomefloxacin.[Drugs and Lactation Database (...]
    Review Lomefloxacin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Norfloxacin.[Drugs and Lactation Database (...]
    Review Norfloxacin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Enoxacin.[Drugs and Lactation Database (...]
    Review Enoxacin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Gatifloxacin.[Drugs and Lactation Database (...]
    Review Gatifloxacin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Ciprofloxacin.[Drugs and Lactation Database (...]
    Review Ciprofloxacin.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...